Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

GSK’s two new cancer drugs look promising

December 2, 2022 Research and Development

GlaxoSmithKline (GSK) appear to be making some positive progress in their oncology department, with drugs for both myelofibrosis and endometrial …
News

Elon Musk’s Neuralink to conduct human trials in 2023

December 1, 2022 Research and Development

Neuralink owner Elon Musk announced that he has submitted paperwork to the FDA which he hopes will allow Neuralink to …
News

Stem cell transplants could be offered to MS patients in new trial

November 30, 2022 Research and Development

In a world-first trial, the University of Sheffield and Sheffield Teaching Hospital NHS Foundation Trust will investigate the efficacy of …
News

Collaboration between BioNTech and Ryvu Therapeutics to develop and commercialise immuno-modulatory small molecule candidates

November 30, 2022 Research and Development

Ryvu Therapeutics, a clinical-stage oncology therapeutics development company, has announced a collaboration with BioNTech, which will consist of two parts: …
News

New Alzheimer’s drug, lecanemab slows disease but divides opinions

November 30, 2022 Research and Development

Japanese drugmaker Eisai and its US partner Biogen have announced that their new drug to treat Alzheimer’s disease appeared to …
News

RadNet’s Aidence AI subsidiary and Google Health enter into agreement to bring lung cancer screening model to market

November 30, 2022 Research and Development

Aidence, an AI subsidiary of RadNet which looks at lung health, has partnered with Google Health to license Google Health’s …
News

University of Texas and Novartis Pharmaceuticals develop new computer platform for easier drug discovery

November 29, 2022 Research and Development

Researchers from both the University of Texas, US and Novartis Pharmaceuticals have developed a computer-based platform which appears to make …
News

Two-dose chemotherapy drug enters clinical trial for cancer patients

November 28, 2022 Research and Development

South Korean biotech firm Hyundai Bioscience’s innovative chemotherapy drug may be able to complete cancer treatments in two doses. The …
News

Lunit first SaMD in APAC region to secure CE mark and UKCA certification for AI-based radiology solution

November 23, 2022 Research and Development

Lunit, a South Korean medical software company, has become the first software as a medical device (SaMD) company in the …
News

BioInnovation Institute reveals new cohort entering Venture Lab programme

September 7, 2022 Research and Development

 The group consists of nine ventures plus two corporate-sponsored innovation projects from Novo Nordisk – all aligned with BII’s focus …
News

New study reveals the range of co-morbidities faced by patients with type 2 diabetes

August 24, 2022 Research and Development

A new study has revealed the range and type of illnesses that people with type 2 diabetes are living with, …
News

Oxford Uni scientists study Siga’s Tpoxx for protection against monkeypox

August 24, 2022 Research and Development

The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ …
News

Paediatric Investigation Plan approved by MHRA

August 24, 2022 Research and Development

Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, …
News

Togo becomes first country to eliminate four neglected tropical diseases

August 24, 2022 Research and Development

WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected …
News
dna-g009a668c7_1280

Evonetix commences access programme for synthesised DNA

August 17, 2022 Research and Development

Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Evonetix has announced the opening …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025